Piramal Pharma Limited (NSE:PPLPHARMA)

Piramal Pharma Revenue

In the fiscal year ending March 31, 2026, Piramal Pharma had annual revenue of 88.69B INR, down -3.08%. Piramal Pharma had revenue of 27.52B in the quarter ending March 31, 2026, a decrease of -0.08%.

• Revenue: 88.69B
• Revenue Growth: -3.08%
• P/S Ratio: 2.65
• Revenue / Employee: 12.46M
• Employees: 7,120
• Market Cap: 235.12B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	88.69B	-2.82B	-3.08%
Mar 31, 2025	91.51B	9.80B	11.99%
Mar 31, 2024	81.71B	10.90B	15.39%
Mar 31, 2023	70.82B	3.47B	5.16%
Mar 31, 2022	67.34B	8.47B	14.39%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 10, 2026

Data Sources Report a data error